B
Bright Minds Biosciences Inc
CNSX:DRUG
Bright Minds Biosciences Inc
CNSX:DRUG
Price:
123.14
CAD
-0.29%
Market Closed
Market Cap:
CA$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
CA |
|
Anker Innovations Technology Co Ltd
SZSE:300866
|
CN |
|
China Haisum Engineering Co Ltd
SZSE:002116
|
CN |
|
Sichuan New Energy Power Co Ltd
SZSE:000155
|
CN |
|
Mclon Jewellery Co Ltd
SZSE:300945
|
CN |
Income Statement
Earnings Waterfall
Bright Minds Biosciences Inc
Bright Minds Biosciences Inc
Income Statement
Bright Minds Biosciences Inc
Bright Minds Biosciences Inc
Currency: CAD
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(9)
|
(13)
|
(16)
|
(15)
|
(15)
|
(12)
|
(10)
|
(9)
|
(7)
|
(7)
|
(5)
|
(4)
|
(3)
|
(3)
|
(6)
|
(9)
|
(14)
|
(19)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Research & Development |
(6)
|
(10)
|
(13)
|
(12)
|
(12)
|
(10)
|
(7)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(1)
|
(2)
|
(4)
|
(7)
|
(11)
|
(16)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(9)
N/A
|
(13)
-48%
|
(16)
-22%
|
(15)
+6%
|
(15)
0%
|
(12)
+17%
|
(10)
+20%
|
(9)
+12%
|
(7)
+16%
|
(7)
+8%
|
(5)
+22%
|
(4)
+32%
|
(3)
+22%
|
(3)
+3%
|
(6)
-102%
|
(9)
-64%
|
(14)
-54%
|
(19)
-38%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
2
|
2
|
(0)
|
2
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(9)
N/A
|
(13)
-48%
|
(16)
-23%
|
(15)
+6%
|
(15)
-1%
|
(12)
+17%
|
(10)
+20%
|
(9)
+12%
|
(7)
+16%
|
(7)
+9%
|
(5)
+22%
|
(4)
+32%
|
(3)
+21%
|
(1)
+62%
|
(3)
-223%
|
(9)
-159%
|
(12)
-37%
|
(20)
-62%
|
|
| Net Income | |||||||||||||||||||
| Income from Continuing Operations |
(9)
|
(13)
|
(16)
|
(15)
|
(15)
|
(12)
|
(10)
|
(9)
|
(7)
|
(7)
|
(5)
|
(4)
|
(3)
|
(1)
|
(3)
|
(9)
|
(12)
|
(20)
|
|
| Net Income (Common) |
(9)
N/A
|
(13)
-48%
|
(16)
-23%
|
(15)
+6%
|
(15)
-1%
|
(12)
+17%
|
(10)
+20%
|
(9)
+12%
|
(7)
+16%
|
(7)
+9%
|
(5)
+22%
|
(4)
+32%
|
(3)
+21%
|
(1)
+62%
|
(3)
-223%
|
(9)
-159%
|
(12)
-37%
|
(20)
-62%
|
|
| EPS (Diluted) |
-4.82
N/A
|
-5.42
-12%
|
-6.64
-23%
|
-6.27
+6%
|
-6.06
+3%
|
-3.46
+43%
|
-2.64
+24%
|
-2.33
+12%
|
-1.98
+15%
|
-1.74
+12%
|
-1.17
+33%
|
-0.76
+35%
|
-0.65
+14%
|
-0.17
+74%
|
-0.48
-182%
|
-1.25
-160%
|
-1.78
-42%
|
-2.55
-43%
|
|
Switch to:
Switch to:
See Also
Discover More
